A Method For Improving The Activity Of An Antibody

  • Published: Dec 11, 2006
  • Earliest Priority: Mar 25 1999
  • Family: 80
  • Cited Works: 0
  • Cited by: 1
  • Cites: 0
  • Additional Info:

The full document isn't yet available to us from the patent office, but we've found a related patent (family member) to use for our images and PDF.


Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the inveniton are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.


Information currently unavailable.

IPC Classifications

Download Citation

Sign in to the Lens